Actively Recruiting
The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients
Led by Hospital Civil de Guadalajara · Updated on 2026-03-12
315
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
H
Hospital Civil de Guadalajara
Lead Sponsor
I
Instituto Jalisciense de Cancerologia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Most recent guidelines suggest central venous access must be performed with real-time ultrasound guidance, and the most recommended site for cannulation is internal jugular vein (IJV); however, it is recognized that evidence for other sites is, at present, limited. Besides, guidelines does not account for patients with small vein cross-sectional area and/or respirophasic collapse, which can make the procedure more difficult or even impossible. The investigators aim to compare three different insertion sites for central venous access, with real-time ultrasound guidance
CONDITIONS
Official Title
The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who need central venous catheterization and have respirophasic variation in cross-sectional area of jugular veins
You will not qualify if you...
- Younger than 18 years old
- Patients with previous failed attempts with non-ultrasound guided technique
- Non-resolved pneumothorax or hemothorax at enrollment
- Refusal to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Civil Fray Antonio Alcalde
Guadalajara, Mexico, 44280
Actively Recruiting
Research Team
M
Miguel Ibarra-Estrada, MD
CONTACT
G
Guadalupe Aguirre-Avalos, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here